Hexadecylphosphoserine (TFA)

• Description :

  Hexadecylphosphoserine TFA is a phospholipid molecule that contains a long-chain alkyl (hexadecyl) and a phosphoserine group, giving it a high affinity for the cell membrane. Hexadecylphosphoserine TFA can exert antitumor activity by modulating [Ca++]i and its related signaling pathways, making it useful for research in the field of breast cancer[1].

• UNSPSC :

  12352211

• Target :

  Calcium Channel

• Related Pathways :

  Membrane Transporter/Ion Channel; Neuronal Signaling

• Applications :

  Cancer-programmed cell death

• Field of Research :

  Cancer

• Purity :

  98.0

• Smiles :

  OC([C@@H](N)COP(OCCCCCCCCCCCCCCCC)(O)=O)=O.OC(C(F)(F)F)=O

• Molecular Formula :

  C21H41F3NO8P

• Molecular Weight :

  523.52

• References & Citations :

  [1]Bergmann J, et al. Multiple effects of antitumor alkyl-lysophospholipid analogs on the cytosolic free Ca2+ concentration in a normal and a breast cancer cell line. Anticancer Res. 1994 Jul-Aug;14 (4A) :1549-56.

• Shipping Conditions :

  Room Temperature

• Storage Conditions :

  4°C (Powder, stored under nitrogen)

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported